SlideShare a Scribd company logo
1 of 24
Dallas A Forshew, RN, BSN 
Manager, Clinical Research 
Forbes Norris ALS Research Center 
California Pacific Medical Center, San Francisco
Outline 
Statement of the problem 
Definition of FTD and variants 
Overview of ALS CBS™ 
How to administer ALS CBS™ 
How to score ALS CBS™ 
Resources
What is Frontotemporal Dementia? 
FTD: severe form of cognitive / behavioral impairment 
Frontal and/or temporal areas of brain are damaged and start to 
slowly atrophy 
May start with 
 Poor decision making (executive dysfunction) 
 Personality changes or behavior problems (behavior variant) or 
 Language difficulty (trouble finding words) 
Gets worse as time passes. Does not get better. 
Patients with easy crying or laughing (pseudobulbar) do not have 
this problem more than other ALS patients 
Clear criteria for uncovering FTD (Neary, 1998) 
Not at all like Alzheimer’s disease (memory mostly stays normal)
FTD is not new in ALS 
Old descriptions 
Withdrawn due to 
depression 
Stubborn 
Seeking control in some 
area of life 
Anger outbursts due to 
frustration of ALS 
Denial 
Language problems due 
to dysarthria 
FTD behaviors 
Apathetic 
Dis-inhibited 
Poor judgement 
Easily frustrated 
Quick to anger 
Lack of insight 
Language difficulty 
Word finding 
Spelling 
Aphasia
Incidence of FTD in ALS 
FTD 22% 
AD 4% 
Normal 
48% 
Not normal, 
Not FTD 26% 
Normal 48% 
FTD 22% 
AD 4% 
Behavior 
Variant 17% 
Executive 
Dysfunction 
9% 
The 26% that is not normal but also not ALS/FTD is redefined as 
ALSci (Executive Dysfunction 9%), ALSbv (Behavior Variant 17%) 
Lomen-Hoerth C, Murphy J
ALS in FTD 
36 patients with sporadic FTD and no known 
motor neuron disease 
14% definite ALS 
36% possible ALS 
14% fasciculations (1 pt = definite ALS after 1 yr) 
17% swallowing trouble 
5% other abnormalities 
C. Lomen-Hoerth, T. Anderson, B. Miller, Neurology, 2002
Genetic Overlap of ALS and FTD 
Familial: 10% of ALS, 40% of FTD 
Affected family members may have only ALS, 
only FTD, or both in familial cases 
TDP-43 was discovered to be the major disease 
protein in both ALS and the most common form 
of FTD. Mutations in TDP-43 cause ALS and FTD. 
C9ORF72 is responsible for 20-40% of all familial 
ALS cases and 12% of FTD cases (2011) 
4-8% of sporadic ALS cases and 3% of sporadic 
FTD cases have mutations in C90RF72
Why is this Important? 
ALS patients with cognitive problems, behavioral 
problems, or FTD 
 
• Are half as likely to accept interventions such as NIV 
or PEG 
• They die, on average, a year earlier 
Portet et al. ALS and Other MND 2001;2:23-29 
Hodges et al. Neurology 2001;61:349-354 
Compliance NIV PEG 
ALS-FTD 5 of 18 (28%) 4 of 16 (25%) 
ALS only 14 of 23 (61%) 8 of 12 (67%) 
Olney RK, Lomen-Hoerth C, Forshew DA, et al. ALS/MND 11/2003
Why Screen? Prognosis 
Executive dysfunction is a negative prognostic 
indicator in patients without dementia 
Elanin, et al, Neurology. 2001, 76:1269 
Decreased survival of ALS patients with either 
ALS-FTD or cognitive impairment (executive 
dysfunction)(ALSci) 
ALS-FTD: 23 vs. 34 months (p=0.026) 
ALSci: 24 vs. 38 months (p<0.0001)
ALS CBS™ 
ALS Cognitive Behavioral Screen 
Validated for sensitivity, accuracy, specificity 
Fast 5 minute SCREEN 
Cognitive component 
 Performed by MD, RN, SLP, research coordinator 
 4 sections each worth 5 points 
 Attention, concentration, tracking/monitoring, initiation and 
retrieval 
Behavioral component 
 Self-administered by family member 
 Compares current behavior with past – changes 
 18 questions
Attention: Commands 
I am going to say some commands. Please listen 
carefully and do what I say. 
If patient is unable to indicate with finger, movement can be 
substituted with eyes, arm or other means. 
Point/indicate (with your finger) to the ceiling and then 
to your left. 
Touch your shoulder, point to the floor, then make a 
fist. 
Scoring 
1 point for getting both correct.
Attention: Mental Addition/Language 
I am going to say some phrases. I want you to tell 
me the number of syllables in each. 
For example ‘the table’ has 3 syllables. 
The weather is nice. (correct response: 5) 
Tomorrow will be sunny. (correct response: 7) 
Scoring 
1 point for getting both correct. 
Score 0 if > 20 seconds on either
Attention: 
Eye Movements - Saccades 
Hold up two fingers in front of patient, about 36 inches 
apart, at patient’s eye level. 
Wiggle one finger. Ask the patient to look at the finger that moves 
without moving their head, and then look back at you. Randomly 
move left and right finger, pausing 2 seconds between each trial, 
for a total of 8 trails. 
 Patient Instructions: I am going to hold my fingers up. I want you 
to keep your head straight and look at me. When I wiggle a finger, I 
want you to look at that finger and then look back at me. Try not to 
move your head, only your eyes. Each time I wiggle a finger, look at 
it and then back to me. (Do 1-2 trials with the pt as an example) We 
will do that a few times. Ready? (Do 8 random trials).
Attention: 
Eye Movements – Anti-saccades 
Patient Instructions: Good, next I am going to wiggle a finger 
again, but this time, I want you to look AWAY from the finger that 
moves. For example, if I move this finger (wiggle one) then I want you 
to look at the other finger, not the one that moves, ok? Let’s try it (do 1- 
3 trials). Just like before, try to keep you head still and just move your 
eyes. After each one, look back at me. Ready? (Do 8 random trials). 
Scoring 
Saccades: 1 pt for 8 correct; Anti-saccades 2 pts for 8 correct, 1 for 7 
Scoring errors: This includes any incorrect gaze, even if the patient 
immediately self-corrects. An error is also counted if a patient 
attempts to anticipate your move and looks before you wiggle a 
finger.
Concentration 
I am going to say some numbers. After I say them, I want 
you to say them to me backwards or in reverse order. 
For example, if I say 3-6, you would say 6-3. 
If written, do not allow allow pt to write forward span. 
Discontinue after failure on 2 consecutive trials. 
2-9 (9-2) 7-8-6-4 (4-6-8-7) 
9-4 (4-9) 8-4-1-7 (7-1-8-4) 
8-7-2 (2-7-8) 8-2-5-9-4 (4-9-5-8-2) 
5-8-1 (1-8-5) 5-8-6-3-9 (9-3-6-8-5)
Concentration 
Scoring (Discontinue after failure on 2 consecutive trials.) 
Score for the maximum span correct (2 – 5) 
2-9 (9-2) 7-8-6-4 (4-6-8-7) 
9-4 (4-9) 8-4-1-7 (7-1-8-4) 
8-7-2 (2-7-8) 8-2-5-9-4 (4-9-5-8-2) 
5-8-1 (1-8-5) Score 4 
2-9 (9-2) 7-8-6-4 (4-6-8-7) 
9-4 (4-9) 8-4-1-7 (7-1-8-4) 
8-7-2 (2-7-8) 8-2-5-9-4 (4-9-5-8-2) 
5-8-1 (1-8-5) 5-8-6-3-9 (9-3-6-8-5) Score 4
Tracking / Monitoring: Months 
Please say the months of the year backward, 
starting with December 
Scoring 
Errors include omissions, repetitions, and intrusions 
Score 2 if no errors, 1 if 1 error, 0 if 2 or more errors 
Score 0 if patient took > 60 seconds
Tracking / Monitoring: Alphabet 
Please say (or write) the alphabet for me. 
Scoring 
Mark uncorrected errors, omissions, repetitions, or 
intrusions 
Score 1 for no errors, 0 if any errors
Tracking / Monitoring: 
Alternation Task 
I want you to alternate between numbers and letters 
starting with 1-A, and then 2-B, 3-C, and so on. Please 
continue from there, alternating between number-letter, 
number-letter, in order, without skipping any until I tell 
you to stop. 
4-D 5-E 6-F 7-G 8-H 9-I 10-J 11-K 12-L 13-M 
Scoring 
Errors: Any mistake in sequencing, i.e. 7-H or 8-9 
A consistent error counts as only 1 error i.e. 7-H, 8-I, 9-K 
Score 2 for all correct, 1 for only 1 error, 0 for > 1 error
Initiation and Retrieval 
Say (write) as many words as you can starting with the 
letter F, as quickly as you can, in 1 minute. (Show patient 
Fluency Rules) You cannot say or write the names of 
people, places, or numbers. Please do not say or write the 
same word with just a different ending like truck, trucks. 
(S words can be substituted for F words.) 
Scoring 
Score 3 for > 12 words, 2 for 12-8 words, 1 for 7-5 words, 0 for < 4) 
Errors include repeats, people, places, or numbers 
0 errors score 2 more, 1 error gets 1 more point, 2 or more errors-0 
If 4 or less words, the total score is o, no matter how few errors
Guidelines for Total Score 
This is a SCREENING tool 
Diagnosis of FTD requires extensive testing with a 
qualified neuropsychologist 
 Manual and Instructions: 
Susan Woolley, PhD WoolleS@sutterhealth.org 
Score interpretation 
17-20: Do not support presence of clear cog impairment 
< 16: Suspicion of cognitive impairment 
< 10: Considerable suspicion, further testing needed
Resources 
Family Caregiver Alliance 
800-445-8106 www.caregiver.org 
ALS Association 
800-782-4747 www.alsa.org 
FYI informational fact Sheets 
 ALS and Cognitive Changes: A Guide for Patients and 
Families 
 ALS, Cognitive Impairment & Frontotemporal Lobar 
Dementia (for professionals)
Many Thanks 
Forbes Norris ALS Research Center 
Susan Woolley, PhD 
WooleS@sutterhealth.org 
ALS Center at UCSF 
Catherine Lomen-Hoerth, MD, PhD 
Jennifer Murphy, PhD 
ForsheD@cpmcri.org
References 
Woolley SC, York MK, Moore DH et al. Detecting frontotemporal 
dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen 
(ALS-CBS™). Amyotroph Lateral Scler 2010; 11(3): 303-311. 
Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller 
B. Are amyotrophic lateral sclerosis patients cognitively normal? 
Neurology 2003; 60(7):1094-1097. 
Olney R, Murphy J, Forshew D, Garwood E, Miller B, Langmore S, 
Kohn M, Lomen-Hoerth C. The effects of executive and behavioral 
dysfunction on the course of ALS. Neurology 2005; 65: 1774-1777.

More Related Content

Similar to Presentation 229 a dallas forshew_ the als cognitive behavorial screen_als cbs_fast tool to use in the clinc.2014

Neurological Assessment97 03
Neurological Assessment97 03Neurological Assessment97 03
Neurological Assessment97 03grunzie
 
Emergency Department and Outpatient Senior Healthcare Consultant Course
Emergency Department and Outpatient Senior Healthcare Consultant CourseEmergency Department and Outpatient Senior Healthcare Consultant Course
Emergency Department and Outpatient Senior Healthcare Consultant Coursenomadicnurse
 
Neurological Assessment for nursing students ppt
Neurological Assessment for nursing students pptNeurological Assessment for nursing students ppt
Neurological Assessment for nursing students pptblessyjannu21
 
Rivermead Assessment of Somatosensory Performance
Rivermead Assessment of Somatosensory PerformanceRivermead Assessment of Somatosensory Performance
Rivermead Assessment of Somatosensory Performancestanbridge
 
alteredsensoriumfinal-121001012445-phpapp02.pdf
alteredsensoriumfinal-121001012445-phpapp02.pdfalteredsensoriumfinal-121001012445-phpapp02.pdf
alteredsensoriumfinal-121001012445-phpapp02.pdfDeepshikhaSinghmar
 
Mental Health and Cognitive Changes in the Older Adult
Mental Health and Cognitive Changes in the Older AdultMental Health and Cognitive Changes in the Older Adult
Mental Health and Cognitive Changes in the Older AdultPaul McNamara
 
Alzheimers Diseaseo Prepare· Review the interactive me.docx
Alzheimers Diseaseo Prepare· Review the interactive me.docxAlzheimers Diseaseo Prepare· Review the interactive me.docx
Alzheimers Diseaseo Prepare· Review the interactive me.docxjack60216
 
Neuro Exam Portfolio
Neuro Exam PortfolioNeuro Exam Portfolio
Neuro Exam PortfolioSteven Sager
 
Neurological assessment.
Neurological assessment.Neurological assessment.
Neurological assessment.Gianne Gregorio
 
Using NIH Stroke Scale and Accurate Documentation for Better Patient Outcomes
Using NIH Stroke Scale and Accurate Documentation for Better Patient OutcomesUsing NIH Stroke Scale and Accurate Documentation for Better Patient Outcomes
Using NIH Stroke Scale and Accurate Documentation for Better Patient OutcomesMedical Transcription Service Company
 
Hydrodilatation distension for frozen shoulder wrightington 2011
Hydrodilatation distension for frozen shoulder wrightington 2011Hydrodilatation distension for frozen shoulder wrightington 2011
Hydrodilatation distension for frozen shoulder wrightington 2011Lennard Funk
 
Dementia and Delirium
Dementia and DeliriumDementia and Delirium
Dementia and DeliriumPaul McNamara
 
Examination of lower limb in neurology-Short case approach for Final MBBS
Examination of lower limb in neurology-Short case approach for Final MBBSExamination of lower limb in neurology-Short case approach for Final MBBS
Examination of lower limb in neurology-Short case approach for Final MBBSYapa
 
PSYCHOLOGY GROUP EYE TEST.pptx
PSYCHOLOGY GROUP EYE TEST.pptxPSYCHOLOGY GROUP EYE TEST.pptx
PSYCHOLOGY GROUP EYE TEST.pptxtomisindurojaye
 

Similar to Presentation 229 a dallas forshew_ the als cognitive behavorial screen_als cbs_fast tool to use in the clinc.2014 (20)

The 10 Min Geriatric Assessment
The 10 Min Geriatric AssessmentThe 10 Min Geriatric Assessment
The 10 Min Geriatric Assessment
 
Neurological Assessment97 03
Neurological Assessment97 03Neurological Assessment97 03
Neurological Assessment97 03
 
Nihss
NihssNihss
Nihss
 
Emergency Department and Outpatient Senior Healthcare Consultant Course
Emergency Department and Outpatient Senior Healthcare Consultant CourseEmergency Department and Outpatient Senior Healthcare Consultant Course
Emergency Department and Outpatient Senior Healthcare Consultant Course
 
Neurological Assessment for nursing students ppt
Neurological Assessment for nursing students pptNeurological Assessment for nursing students ppt
Neurological Assessment for nursing students ppt
 
Rivermead Assessment of Somatosensory Performance
Rivermead Assessment of Somatosensory PerformanceRivermead Assessment of Somatosensory Performance
Rivermead Assessment of Somatosensory Performance
 
alteredsensoriumfinal-121001012445-phpapp02.pdf
alteredsensoriumfinal-121001012445-phpapp02.pdfalteredsensoriumfinal-121001012445-phpapp02.pdf
alteredsensoriumfinal-121001012445-phpapp02.pdf
 
Mental Health and Cognitive Changes in the Older Adult
Mental Health and Cognitive Changes in the Older AdultMental Health and Cognitive Changes in the Older Adult
Mental Health and Cognitive Changes in the Older Adult
 
Alzheimers Diseaseo Prepare· Review the interactive me.docx
Alzheimers Diseaseo Prepare· Review the interactive me.docxAlzheimers Diseaseo Prepare· Review the interactive me.docx
Alzheimers Diseaseo Prepare· Review the interactive me.docx
 
Neuro
NeuroNeuro
Neuro
 
MRCP PACES.ppt
MRCP PACES.pptMRCP PACES.ppt
MRCP PACES.ppt
 
Pcpc kuistionare
Pcpc kuistionarePcpc kuistionare
Pcpc kuistionare
 
Neuro Exam Portfolio
Neuro Exam PortfolioNeuro Exam Portfolio
Neuro Exam Portfolio
 
Neurological assessment.
Neurological assessment.Neurological assessment.
Neurological assessment.
 
Using NIH Stroke Scale and Accurate Documentation for Better Patient Outcomes
Using NIH Stroke Scale and Accurate Documentation for Better Patient OutcomesUsing NIH Stroke Scale and Accurate Documentation for Better Patient Outcomes
Using NIH Stroke Scale and Accurate Documentation for Better Patient Outcomes
 
Hydrodilatation distension for frozen shoulder wrightington 2011
Hydrodilatation distension for frozen shoulder wrightington 2011Hydrodilatation distension for frozen shoulder wrightington 2011
Hydrodilatation distension for frozen shoulder wrightington 2011
 
Dementia and Delirium
Dementia and DeliriumDementia and Delirium
Dementia and Delirium
 
Examination of lower limb in neurology-Short case approach for Final MBBS
Examination of lower limb in neurology-Short case approach for Final MBBSExamination of lower limb in neurology-Short case approach for Final MBBS
Examination of lower limb in neurology-Short case approach for Final MBBS
 
PSYCHOLOGY GROUP EYE TEST.pptx
PSYCHOLOGY GROUP EYE TEST.pptxPSYCHOLOGY GROUP EYE TEST.pptx
PSYCHOLOGY GROUP EYE TEST.pptx
 
Global Medical Cures™| NIH STROKE SCALE
Global Medical Cures™| NIH STROKE SCALEGlobal Medical Cures™| NIH STROKE SCALE
Global Medical Cures™| NIH STROKE SCALE
 

More from The ALS Association

The Clinical Application of Tele-health in the care of people with ALS
The Clinical Application of Tele-health in the care of people with ALSThe Clinical Application of Tele-health in the care of people with ALS
The Clinical Application of Tele-health in the care of people with ALSThe ALS Association
 
Optimizing Respiratory Care in ALS
Optimizing Respiratory Care in ALSOptimizing Respiratory Care in ALS
Optimizing Respiratory Care in ALSThe ALS Association
 
Presentation 205 sagan living with change, dx to death
Presentation 205 sagan living with change, dx to deathPresentation 205 sagan living with change, dx to death
Presentation 205 sagan living with change, dx to deathThe ALS Association
 
Presentation 212 d gardner_the pyramid of care for als
Presentation 212 d gardner_the pyramid of care for alsPresentation 212 d gardner_the pyramid of care for als
Presentation 212 d gardner_the pyramid of care for alsThe ALS Association
 
Presentation 217 dallas forshew decoding stem cells for als 2014
Presentation 217 dallas forshew  decoding stem cells for als  2014Presentation 217 dallas forshew  decoding stem cells for als  2014
Presentation 217 dallas forshew decoding stem cells for als 2014The ALS Association
 
Presentation 202 jennifer kennedy hospice and pallative care for a patient...
Presentation 202  jennifer kennedy  hospice and pallative care for  a patient...Presentation 202  jennifer kennedy  hospice and pallative care for  a patient...
Presentation 202 jennifer kennedy hospice and pallative care for a patient...The ALS Association
 
Presentation 224 a barnes_klapper_laregina_ashley fund ppt oct 2014
Presentation 224 a barnes_klapper_laregina_ashley fund ppt oct  2014Presentation 224 a barnes_klapper_laregina_ashley fund ppt oct  2014
Presentation 224 a barnes_klapper_laregina_ashley fund ppt oct 2014The ALS Association
 
Presentation 211 a beth stephens_the utilization of a communication and treat...
Presentation 211 a beth stephens_the utilization of a communication and treat...Presentation 211 a beth stephens_the utilization of a communication and treat...
Presentation 211 a beth stephens_the utilization of a communication and treat...The ALS Association
 
Presentation 227 laurie fieldman als families
Presentation 227 laurie fieldman als familiesPresentation 227 laurie fieldman als families
Presentation 227 laurie fieldman als familiesThe ALS Association
 
Presentation 225 a francesca monachino & melissa werz_the keys to driving -...
Presentation 225 a  francesca monachino & melissa werz_the keys to  driving -...Presentation 225 a  francesca monachino & melissa werz_the keys to  driving -...
Presentation 225 a francesca monachino & melissa werz_the keys to driving -...The ALS Association
 
Presentation 221 laurie fieldman children in als families
Presentation 221 laurie fieldman children in als familiesPresentation 221 laurie fieldman children in als families
Presentation 221 laurie fieldman children in als familiesThe ALS Association
 
Presentation 228 denise epps neurogenic dysphagia- role of slp in dysphagia...
Presentation 228  denise epps neurogenic dysphagia- role of slp in  dysphagia...Presentation 228  denise epps neurogenic dysphagia- role of slp in  dysphagia...
Presentation 228 denise epps neurogenic dysphagia- role of slp in dysphagia...The ALS Association
 
Presentation 216 antoinette verdone home accommodations for als_ no contrac...
Presentation 216  antoinette verdone home accommodations for als_  no contrac...Presentation 216  antoinette verdone home accommodations for als_  no contrac...
Presentation 216 antoinette verdone home accommodations for als_ no contrac...The ALS Association
 
Presentation 210 antoinette verdone mobile devices-access and use for pals...
Presentation 210  antoinette verdone  mobile devices-access and use  for pals...Presentation 210  antoinette verdone  mobile devices-access and use  for pals...
Presentation 210 antoinette verdone mobile devices-access and use for pals...The ALS Association
 
Presentation 209 ray onders & mary jo elmo diaphramg pacing- what we have ...
Presentation 209  ray onders & mary jo elmo  diaphramg pacing- what  we have ...Presentation 209  ray onders & mary jo elmo  diaphramg pacing- what  we have ...
Presentation 209 ray onders & mary jo elmo diaphramg pacing- what we have ...The ALS Association
 
Presentation 204 lisa bruening aac in times of change
Presentation 204  lisa bruening aac in times of changePresentation 204  lisa bruening aac in times of change
Presentation 204 lisa bruening aac in times of changeThe ALS Association
 
Presentation 220 richard strozewski building an als telehealth support syst...
Presentation 220  richard strozewski building an als telehealth  support syst...Presentation 220  richard strozewski building an als telehealth  support syst...
Presentation 220 richard strozewski building an als telehealth support syst...The ALS Association
 
Presentation 218 sabrina schalley anticipatory grief in als families
Presentation 218  sabrina schalley anticipatory grief in als  familiesPresentation 218  sabrina schalley anticipatory grief in als  families
Presentation 218 sabrina schalley anticipatory grief in als familiesThe ALS Association
 
Presentation 214 b. bartja wachtel meaningful_the life practice of mindful ...
Presentation 214  b. bartja wachtel meaningful_the life practice of  mindful ...Presentation 214  b. bartja wachtel meaningful_the life practice of  mindful ...
Presentation 214 b. bartja wachtel meaningful_the life practice of mindful ...The ALS Association
 
Presentation 208 b sue walsh_an evaluation of newly diagnosed patient needs
Presentation 208 b sue walsh_an evaluation of newly diagnosed  patient needsPresentation 208 b sue walsh_an evaluation of newly diagnosed  patient needs
Presentation 208 b sue walsh_an evaluation of newly diagnosed patient needsThe ALS Association
 

More from The ALS Association (20)

The Clinical Application of Tele-health in the care of people with ALS
The Clinical Application of Tele-health in the care of people with ALSThe Clinical Application of Tele-health in the care of people with ALS
The Clinical Application of Tele-health in the care of people with ALS
 
Optimizing Respiratory Care in ALS
Optimizing Respiratory Care in ALSOptimizing Respiratory Care in ALS
Optimizing Respiratory Care in ALS
 
Presentation 205 sagan living with change, dx to death
Presentation 205 sagan living with change, dx to deathPresentation 205 sagan living with change, dx to death
Presentation 205 sagan living with change, dx to death
 
Presentation 212 d gardner_the pyramid of care for als
Presentation 212 d gardner_the pyramid of care for alsPresentation 212 d gardner_the pyramid of care for als
Presentation 212 d gardner_the pyramid of care for als
 
Presentation 217 dallas forshew decoding stem cells for als 2014
Presentation 217 dallas forshew  decoding stem cells for als  2014Presentation 217 dallas forshew  decoding stem cells for als  2014
Presentation 217 dallas forshew decoding stem cells for als 2014
 
Presentation 202 jennifer kennedy hospice and pallative care for a patient...
Presentation 202  jennifer kennedy  hospice and pallative care for  a patient...Presentation 202  jennifer kennedy  hospice and pallative care for  a patient...
Presentation 202 jennifer kennedy hospice and pallative care for a patient...
 
Presentation 224 a barnes_klapper_laregina_ashley fund ppt oct 2014
Presentation 224 a barnes_klapper_laregina_ashley fund ppt oct  2014Presentation 224 a barnes_klapper_laregina_ashley fund ppt oct  2014
Presentation 224 a barnes_klapper_laregina_ashley fund ppt oct 2014
 
Presentation 211 a beth stephens_the utilization of a communication and treat...
Presentation 211 a beth stephens_the utilization of a communication and treat...Presentation 211 a beth stephens_the utilization of a communication and treat...
Presentation 211 a beth stephens_the utilization of a communication and treat...
 
Presentation 227 laurie fieldman als families
Presentation 227 laurie fieldman als familiesPresentation 227 laurie fieldman als families
Presentation 227 laurie fieldman als families
 
Presentation 225 a francesca monachino & melissa werz_the keys to driving -...
Presentation 225 a  francesca monachino & melissa werz_the keys to  driving -...Presentation 225 a  francesca monachino & melissa werz_the keys to  driving -...
Presentation 225 a francesca monachino & melissa werz_the keys to driving -...
 
Presentation 221 laurie fieldman children in als families
Presentation 221 laurie fieldman children in als familiesPresentation 221 laurie fieldman children in als families
Presentation 221 laurie fieldman children in als families
 
Presentation 228 denise epps neurogenic dysphagia- role of slp in dysphagia...
Presentation 228  denise epps neurogenic dysphagia- role of slp in  dysphagia...Presentation 228  denise epps neurogenic dysphagia- role of slp in  dysphagia...
Presentation 228 denise epps neurogenic dysphagia- role of slp in dysphagia...
 
Presentation 216 antoinette verdone home accommodations for als_ no contrac...
Presentation 216  antoinette verdone home accommodations for als_  no contrac...Presentation 216  antoinette verdone home accommodations for als_  no contrac...
Presentation 216 antoinette verdone home accommodations for als_ no contrac...
 
Presentation 210 antoinette verdone mobile devices-access and use for pals...
Presentation 210  antoinette verdone  mobile devices-access and use  for pals...Presentation 210  antoinette verdone  mobile devices-access and use  for pals...
Presentation 210 antoinette verdone mobile devices-access and use for pals...
 
Presentation 209 ray onders & mary jo elmo diaphramg pacing- what we have ...
Presentation 209  ray onders & mary jo elmo  diaphramg pacing- what  we have ...Presentation 209  ray onders & mary jo elmo  diaphramg pacing- what  we have ...
Presentation 209 ray onders & mary jo elmo diaphramg pacing- what we have ...
 
Presentation 204 lisa bruening aac in times of change
Presentation 204  lisa bruening aac in times of changePresentation 204  lisa bruening aac in times of change
Presentation 204 lisa bruening aac in times of change
 
Presentation 220 richard strozewski building an als telehealth support syst...
Presentation 220  richard strozewski building an als telehealth  support syst...Presentation 220  richard strozewski building an als telehealth  support syst...
Presentation 220 richard strozewski building an als telehealth support syst...
 
Presentation 218 sabrina schalley anticipatory grief in als families
Presentation 218  sabrina schalley anticipatory grief in als  familiesPresentation 218  sabrina schalley anticipatory grief in als  families
Presentation 218 sabrina schalley anticipatory grief in als families
 
Presentation 214 b. bartja wachtel meaningful_the life practice of mindful ...
Presentation 214  b. bartja wachtel meaningful_the life practice of  mindful ...Presentation 214  b. bartja wachtel meaningful_the life practice of  mindful ...
Presentation 214 b. bartja wachtel meaningful_the life practice of mindful ...
 
Presentation 208 b sue walsh_an evaluation of newly diagnosed patient needs
Presentation 208 b sue walsh_an evaluation of newly diagnosed  patient needsPresentation 208 b sue walsh_an evaluation of newly diagnosed  patient needs
Presentation 208 b sue walsh_an evaluation of newly diagnosed patient needs
 

Recently uploaded

Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 

Recently uploaded (20)

Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 

Presentation 229 a dallas forshew_ the als cognitive behavorial screen_als cbs_fast tool to use in the clinc.2014

  • 1. Dallas A Forshew, RN, BSN Manager, Clinical Research Forbes Norris ALS Research Center California Pacific Medical Center, San Francisco
  • 2. Outline Statement of the problem Definition of FTD and variants Overview of ALS CBS™ How to administer ALS CBS™ How to score ALS CBS™ Resources
  • 3. What is Frontotemporal Dementia? FTD: severe form of cognitive / behavioral impairment Frontal and/or temporal areas of brain are damaged and start to slowly atrophy May start with  Poor decision making (executive dysfunction)  Personality changes or behavior problems (behavior variant) or  Language difficulty (trouble finding words) Gets worse as time passes. Does not get better. Patients with easy crying or laughing (pseudobulbar) do not have this problem more than other ALS patients Clear criteria for uncovering FTD (Neary, 1998) Not at all like Alzheimer’s disease (memory mostly stays normal)
  • 4. FTD is not new in ALS Old descriptions Withdrawn due to depression Stubborn Seeking control in some area of life Anger outbursts due to frustration of ALS Denial Language problems due to dysarthria FTD behaviors Apathetic Dis-inhibited Poor judgement Easily frustrated Quick to anger Lack of insight Language difficulty Word finding Spelling Aphasia
  • 5. Incidence of FTD in ALS FTD 22% AD 4% Normal 48% Not normal, Not FTD 26% Normal 48% FTD 22% AD 4% Behavior Variant 17% Executive Dysfunction 9% The 26% that is not normal but also not ALS/FTD is redefined as ALSci (Executive Dysfunction 9%), ALSbv (Behavior Variant 17%) Lomen-Hoerth C, Murphy J
  • 6. ALS in FTD 36 patients with sporadic FTD and no known motor neuron disease 14% definite ALS 36% possible ALS 14% fasciculations (1 pt = definite ALS after 1 yr) 17% swallowing trouble 5% other abnormalities C. Lomen-Hoerth, T. Anderson, B. Miller, Neurology, 2002
  • 7. Genetic Overlap of ALS and FTD Familial: 10% of ALS, 40% of FTD Affected family members may have only ALS, only FTD, or both in familial cases TDP-43 was discovered to be the major disease protein in both ALS and the most common form of FTD. Mutations in TDP-43 cause ALS and FTD. C9ORF72 is responsible for 20-40% of all familial ALS cases and 12% of FTD cases (2011) 4-8% of sporadic ALS cases and 3% of sporadic FTD cases have mutations in C90RF72
  • 8. Why is this Important? ALS patients with cognitive problems, behavioral problems, or FTD  • Are half as likely to accept interventions such as NIV or PEG • They die, on average, a year earlier Portet et al. ALS and Other MND 2001;2:23-29 Hodges et al. Neurology 2001;61:349-354 Compliance NIV PEG ALS-FTD 5 of 18 (28%) 4 of 16 (25%) ALS only 14 of 23 (61%) 8 of 12 (67%) Olney RK, Lomen-Hoerth C, Forshew DA, et al. ALS/MND 11/2003
  • 9. Why Screen? Prognosis Executive dysfunction is a negative prognostic indicator in patients without dementia Elanin, et al, Neurology. 2001, 76:1269 Decreased survival of ALS patients with either ALS-FTD or cognitive impairment (executive dysfunction)(ALSci) ALS-FTD: 23 vs. 34 months (p=0.026) ALSci: 24 vs. 38 months (p<0.0001)
  • 10. ALS CBS™ ALS Cognitive Behavioral Screen Validated for sensitivity, accuracy, specificity Fast 5 minute SCREEN Cognitive component  Performed by MD, RN, SLP, research coordinator  4 sections each worth 5 points  Attention, concentration, tracking/monitoring, initiation and retrieval Behavioral component  Self-administered by family member  Compares current behavior with past – changes  18 questions
  • 11. Attention: Commands I am going to say some commands. Please listen carefully and do what I say. If patient is unable to indicate with finger, movement can be substituted with eyes, arm or other means. Point/indicate (with your finger) to the ceiling and then to your left. Touch your shoulder, point to the floor, then make a fist. Scoring 1 point for getting both correct.
  • 12. Attention: Mental Addition/Language I am going to say some phrases. I want you to tell me the number of syllables in each. For example ‘the table’ has 3 syllables. The weather is nice. (correct response: 5) Tomorrow will be sunny. (correct response: 7) Scoring 1 point for getting both correct. Score 0 if > 20 seconds on either
  • 13. Attention: Eye Movements - Saccades Hold up two fingers in front of patient, about 36 inches apart, at patient’s eye level. Wiggle one finger. Ask the patient to look at the finger that moves without moving their head, and then look back at you. Randomly move left and right finger, pausing 2 seconds between each trial, for a total of 8 trails.  Patient Instructions: I am going to hold my fingers up. I want you to keep your head straight and look at me. When I wiggle a finger, I want you to look at that finger and then look back at me. Try not to move your head, only your eyes. Each time I wiggle a finger, look at it and then back to me. (Do 1-2 trials with the pt as an example) We will do that a few times. Ready? (Do 8 random trials).
  • 14. Attention: Eye Movements – Anti-saccades Patient Instructions: Good, next I am going to wiggle a finger again, but this time, I want you to look AWAY from the finger that moves. For example, if I move this finger (wiggle one) then I want you to look at the other finger, not the one that moves, ok? Let’s try it (do 1- 3 trials). Just like before, try to keep you head still and just move your eyes. After each one, look back at me. Ready? (Do 8 random trials). Scoring Saccades: 1 pt for 8 correct; Anti-saccades 2 pts for 8 correct, 1 for 7 Scoring errors: This includes any incorrect gaze, even if the patient immediately self-corrects. An error is also counted if a patient attempts to anticipate your move and looks before you wiggle a finger.
  • 15. Concentration I am going to say some numbers. After I say them, I want you to say them to me backwards or in reverse order. For example, if I say 3-6, you would say 6-3. If written, do not allow allow pt to write forward span. Discontinue after failure on 2 consecutive trials. 2-9 (9-2) 7-8-6-4 (4-6-8-7) 9-4 (4-9) 8-4-1-7 (7-1-8-4) 8-7-2 (2-7-8) 8-2-5-9-4 (4-9-5-8-2) 5-8-1 (1-8-5) 5-8-6-3-9 (9-3-6-8-5)
  • 16. Concentration Scoring (Discontinue after failure on 2 consecutive trials.) Score for the maximum span correct (2 – 5) 2-9 (9-2) 7-8-6-4 (4-6-8-7) 9-4 (4-9) 8-4-1-7 (7-1-8-4) 8-7-2 (2-7-8) 8-2-5-9-4 (4-9-5-8-2) 5-8-1 (1-8-5) Score 4 2-9 (9-2) 7-8-6-4 (4-6-8-7) 9-4 (4-9) 8-4-1-7 (7-1-8-4) 8-7-2 (2-7-8) 8-2-5-9-4 (4-9-5-8-2) 5-8-1 (1-8-5) 5-8-6-3-9 (9-3-6-8-5) Score 4
  • 17. Tracking / Monitoring: Months Please say the months of the year backward, starting with December Scoring Errors include omissions, repetitions, and intrusions Score 2 if no errors, 1 if 1 error, 0 if 2 or more errors Score 0 if patient took > 60 seconds
  • 18. Tracking / Monitoring: Alphabet Please say (or write) the alphabet for me. Scoring Mark uncorrected errors, omissions, repetitions, or intrusions Score 1 for no errors, 0 if any errors
  • 19. Tracking / Monitoring: Alternation Task I want you to alternate between numbers and letters starting with 1-A, and then 2-B, 3-C, and so on. Please continue from there, alternating between number-letter, number-letter, in order, without skipping any until I tell you to stop. 4-D 5-E 6-F 7-G 8-H 9-I 10-J 11-K 12-L 13-M Scoring Errors: Any mistake in sequencing, i.e. 7-H or 8-9 A consistent error counts as only 1 error i.e. 7-H, 8-I, 9-K Score 2 for all correct, 1 for only 1 error, 0 for > 1 error
  • 20. Initiation and Retrieval Say (write) as many words as you can starting with the letter F, as quickly as you can, in 1 minute. (Show patient Fluency Rules) You cannot say or write the names of people, places, or numbers. Please do not say or write the same word with just a different ending like truck, trucks. (S words can be substituted for F words.) Scoring Score 3 for > 12 words, 2 for 12-8 words, 1 for 7-5 words, 0 for < 4) Errors include repeats, people, places, or numbers 0 errors score 2 more, 1 error gets 1 more point, 2 or more errors-0 If 4 or less words, the total score is o, no matter how few errors
  • 21. Guidelines for Total Score This is a SCREENING tool Diagnosis of FTD requires extensive testing with a qualified neuropsychologist  Manual and Instructions: Susan Woolley, PhD WoolleS@sutterhealth.org Score interpretation 17-20: Do not support presence of clear cog impairment < 16: Suspicion of cognitive impairment < 10: Considerable suspicion, further testing needed
  • 22. Resources Family Caregiver Alliance 800-445-8106 www.caregiver.org ALS Association 800-782-4747 www.alsa.org FYI informational fact Sheets  ALS and Cognitive Changes: A Guide for Patients and Families  ALS, Cognitive Impairment & Frontotemporal Lobar Dementia (for professionals)
  • 23. Many Thanks Forbes Norris ALS Research Center Susan Woolley, PhD WooleS@sutterhealth.org ALS Center at UCSF Catherine Lomen-Hoerth, MD, PhD Jennifer Murphy, PhD ForsheD@cpmcri.org
  • 24. References Woolley SC, York MK, Moore DH et al. Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™). Amyotroph Lateral Scler 2010; 11(3): 303-311. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003; 60(7):1094-1097. Olney R, Murphy J, Forshew D, Garwood E, Miller B, Langmore S, Kohn M, Lomen-Hoerth C. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005; 65: 1774-1777.